What is the share price of Amanta Healthcare Ltd (AMANTA) today?
The share price of AMANTA as on 16th September 2026 is ₹189.93. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Amanta Healthcare Ltd (AMANTA) share?
The past returns of Amanta Healthcare Ltd (AMANTA) share are- Past 1 week: -7.75%
- Past 1 month: 22.54%
- Past 3 months: 26.39%
- Past 6 months: 94.90%
- Past 1 year: 33.87%
- Past 3 years: N/A%
- Past 5 years: 33.99%
What are the peers or stocks similar to Amanta Healthcare Ltd (AMANTA)?
The peers or stocks similar to Amanta Healthcare Ltd (AMANTA) include:What is the market cap of Amanta Healthcare Ltd (AMANTA) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Amanta Healthcare Ltd (AMANTA) is ₹737.49 Cr as of 16th September 2026.What is the 52 week high and low of Amanta Healthcare Ltd (AMANTA) share?
The 52-week high of Amanta Healthcare Ltd (AMANTA) is ₹209.95 and the 52-week low is ₹92.What is the PE and PB ratio of Amanta Healthcare Ltd (AMANTA) stock?
The P/E (price-to-earnings) ratio of Amanta Healthcare Ltd (AMANTA) is 49.60. The P/B (price-to-book) ratio is 3.35.Which sector does Amanta Healthcare Ltd (AMANTA) belong to?
Amanta Healthcare Ltd (AMANTA) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Amanta Healthcare Ltd (AMANTA) shares?
You can directly buy Amanta Healthcare Ltd (AMANTA) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Amanta Healthcare Ltd
AMANTA Share Price
NSE₹189.932.00% (-3.87)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
AMANTA Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
AMANTA Performance & Key Metrics
AMANTA Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 50.20 | 3.35 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 46.17 | 5.79 | 0.49% |
AMANTA Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
AMANTA Company Profile
Amanta Healthcare Ltd develops, manufactures, and markets sterile liquid parenteral products including large and small volume parenterals across six therapeutic segments, and medical devices with advanced packaging technologies in India.
SUNPHARMA
PE Ratio
38.74
38.74
1Y Return
15.08%
15.08%
Buy Reco %
93.55
93.55
TORNTPHARM
PE Ratio
84.61
84.61
1Y Return
36.60%
36.60%
Buy Reco %
81.48
81.48
ZYDUSLIFE
PE Ratio
21.92
21.92
1Y Return
6.59%
6.59%
Buy Reco %
57.69
57.69
CIPLA
PE Ratio
28.28
28.28
1Y Return
12.89%
12.89%
Buy Reco %
62.86
62.86
LAURUSLABS
PE Ratio
115.84
115.84
1Y Return
112.52%
112.52%
Buy Reco %
58.33
58.33
AMANTA Sentiment Analysis
AMANTA Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
AMANTA Stock Summary · August 2026
Management’s message was that growth remained intact despite near-term cost and timing pressure, with Q1 FY27 revenue up about 5% year on year to INR69 crores and EBITDA at roughly INR15 crores, while margins stayed near 22%. They said profitability held up through operational discipline and better price realization, even as raw material, employee and startup-related costs, plus a slowdown linked to the Iran war situation, weighed on performance. SteriPort has become the main growth engine, now contributing around 44% of revenue, and management emphasized strong customer acceptance and the buildout of capacity from 6.6 crore to about 12 crore bottles a year. Although the new line slipped from Q1 to Q2 FY27 because of civil construction issues, they said the plan is unchanged and expect commercial production in late August, with the line adding operating leverage over time. The company also highlighted lower power costs from its 10.8 MW captive solar project and the upcoming SVP facility. Near term, management kept full-year revenue guidance at about INR370 crores excluding SVP, with peak revenue around INR425 crores and EBITDA of about INR116 crores.
AMANTA Stock Growth Drivers
AMANTA Stock Growth Drivers
8Resilient Revenue Growth and Profitability
The company delivered resilient quarterly performance despite inflationary pressure, higher operating costs, and some segment
SteriPort as a Core Growth Engine
SteriPort has emerged as a major revenue contributor and an important strategic platform, accounting for
AMANTA Stock Challenges
AMANTA Stock Challenges
6Delays in capacity expansion and new line commissioning
The company’s near-term growth plans have been slowed by repeated execution delays in expanding SteriPort
Near-term margin pressure from inflation and polymer volatility
Profitability is facing pressure from a difficult cost environment, including inflation, higher operating expenses, and
AMANTA Forecast
AMANTA Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
AMANTA
AMANTA
Income
Balance Sheet
Cash Flow
Quarterly Normal View
AMANTA Income Statement
AMANTA Income Statement
Quarterly Normal View
| Quarter | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 68.24 | 66.94 | 68.68 | 72.22 | 66.27 | 70.96 | 75.16 | 78.66 | 69.45 | |||||||||
Operating & Other expenses | 54.70 | 52.85 | 52.75 | 53.10 | 50.41 | 58.87 | 59.13 | 62.04 | 54.26 | |||||||||
EBITDA | 13.54 | 14.09 | 15.93 | 19.12 | 15.86 | 12.09 | 16.03 | 16.62 | 15.19 | |||||||||
| Depreciation/Amortization | 4.60 | 4.60 | 4.51 | 4.69 | 4.64 | 4.66 | 4.67 | 4.75 | 4.69 | |||||||||
| PBIT | 8.94 | 9.49 | 11.42 | 14.43 | 11.22 | 7.43 | 11.36 | 11.87 | 10.50 | |||||||||
| Interest & Other Items | 9.45 | 6.32 | 5.90 | 6.28 | 6.29 | 5.15 | 5.06 | 4.25 | 6.00 | |||||||||
| PBT | -0.51 | 3.17 | 5.52 | 8.15 | 4.93 | 2.28 | 6.30 | 7.62 | 4.50 | |||||||||
| Taxes & Other Items | -0.14 | 0.91 | 1.25 | 2.19 | 1.42 | 1.07 | 1.67 | 2.09 | 1.18 | |||||||||
| Net Income | -0.37 | 2.26 | 4.27 | 5.96 | 3.51 | 1.21 | 4.63 | 5.53 | 3.32 | |||||||||
| EPS | -0.13 | 0.80 | 1.51 | 2.11 | 1.22 | 0.35 | 1.35 | 1.61 | 0.85 |
AMANTA Company Updates
FY 2027FY 2027
Investor Presentation
Aug 5PDF
AMANTA Stock Peers
AMANTA Past Performance & Peer Comparison
AMANTA Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Amanta Healthcare Ltd | 49.60 | 3.35 | — |
| Sun Pharmaceutical Industries Ltd | 38.74 | 5.30 | 0.86% |
| Torrent Pharmaceuticals Ltd | 84.61 | 10.41 | 0.70% |
| Zydus Lifesciences Ltd | 21.92 | 3.73 | 0.09% |
AMANTA Stock Price Comparison
Compare AMANTA with any stock or ETFCompare AMANTA with any stock or ETF
AMANTA
AMANTA Holdings
AMANTA Shareholdings
AMANTA Promoter Holdings Trend
AMANTA Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
AMANTA Institutional Holdings Trend
AMANTA Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
AMANTA Shareholding Pattern
AMANTA Shareholding Pattern
AMANTA Shareholding History
AMANTA Shareholding History
Foreign Institutions
Mutual Funds Invested in AMANTA
Mutual Funds Invested in AMANTA
No mutual funds holding trends are available
Top 1 Mutual Funds holding Amanta Healthcare Ltd
| Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 4.9872% | Percentage of the fund’s portfolio invested in the stock 0.11% | Change in the portfolio weight of the stock over the last 3 months -0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 191/277 (-3) |
Compare 3-month MF holding change on Screener
smallcases containing AMANTA stock
smallcases containing AMANTA stock
Looks like this stock is not in any smallcase yet.
AMANTA Events
AMANTA Events
AMANTA Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
AMANTA has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
AMANTA Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
AMANTA has not given any dividends in last 5 years
AMANTA Dividends
AMANTA Dividends
Hmm, looks like data is unavailable here. Please come back after some timeAMANTA Stock News & Opinions
AMANTA Stock News & Opinions
Articles & Videos
Corporate
Corporate
Amanta Healthcare shareholders approved director and auditor appointments at their annual meetingAMANTA HEALTHCARE LIMITED announced that its shareholders approved the appointment of Mr. Nimesh P Patel (DIN: 09044772) as a director retiring by rotation, and the appointment of M/s. Kashyap R. Mehta & Partners as Secretarial Auditor for a five-year term commencing from the financial year 2026-27 till the financial year 2030-31, at the company's 31st Annual General Meeting held on September 16, 2026.
4 hours agoCapital Market - Live
Corporate
Corporate
Amanta Healthcare reports Rs 68.8 crore revenue, profit after tax declines year-over-yearAmanta Healthcare Limited (BSE: 544502, NSE: AMANTA) announced its unaudited financial results for the quarter ended June 30, 2026, reporting revenue of Rs 68.8 crore, a 5.4% year-over-year increase, driven by improved product mix and better price realizations, while profit after tax declined to Rs 3.3 crore from Rs 3.5 crore in the prior year due to higher finance costs. The company's EBITDA stood at Rs 15.2 crore, with margins moderating to 22% from 24% a year ago, and plans to commission the Steriport plant in the second quarter of fiscal year 2027 and the SVP expansion in the fourth quarter of fiscal year 2027 are expected to enhance manufacturing capacity and cost efficiency.
1 month agoCapital Market - Live
Corporate
Corporate
Amanta Healthcare appoints Nilesh Punjabi as Senior Management Personnel, effective August 5, 2026AMANTA HEALTHCARE LIMITED announced on August 5, 2026, that its Board of Directors approved the inclusion of Mr. Nilesh Punjabi, Assistant Vice President (HR & Admin), as a Senior Management Personnel (SMP), as recommended by the Nomination and Remuneration Committee. Mr. Punjabi holds an MBA in Human Resource Development from South Gujarat University and a Post Graduate degree in HRM from XLRI Jamshedpur, and previously served as the Zonal Head of HR at United Breweries Ltd.
1 month agoCapital Market - Live
Corporate
Corporate
Amanta Healthcare to review quarterly results at board meeting on August 5, 2026Amanta Healthcare Limited will hold a board meeting on Wednesday, August 5, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, according to a filing with the BSE Limited and National Stock Exchange of India Limited. The trading window, previously closed from Wednesday, July 1, 2026, will reopen on Saturday, August 8, 2026, in compliance with SEBI regulations.
1 month agoCapital Market - Live
Earnings
Earnings
Amanta Healthcare standalone net profit declines 7.21% in the March 2026 quarterNet profit of Amanta Healthcare declined 7.21% to Rs 5.53 crore in the quarter ended March 2026 as against Rs 5.96 crore during the previous quarter ended March 2025. Sales rose 6.84% to Rs 76.99 crore in the quarter ended March 2026 as against Rs 72.06 crore during the previous quarter ended March 2025. For the full year,net profit rose 41.71% to Rs 14.88 crore in the year ended March 2026 as against Rs 10.50 crore during the previous year ended March 2025. Sales rose 4.72% to Rs 287.68 crore in the year ended March 2026 as against Rs 274.71 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales76.9972.06 7 287.68274.71 5 OPM %19.4326.31 -20.8121.72 - PBDT12.3712.84 -4 42.4933.10 28 PBT7.628.15 -7 23.7614.70 62 NP5.535.96 -7 14.8810.50 42 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Corporate
Amanta Healthcare to hold board meetingAmanta Healthcare will hold a meeting of the Board of Directors of the Company on 19 May 2026.
4 months agoCapital Market - Live
Earnings
Earnings
Amanta Healthcare standalone net profit rises 8.18% in the December 2025 quarterNet profit of Amanta Healthcare rose 8.18% to Rs 4.63 crore in the quarter ended December 2025 as against Rs 4.28 crore during the previous quarter ended December 2024. Sales rose 9.85% to Rs 74.49 crore in the quarter ended December 2025 as against Rs 67.81 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales74.4967.81 10 OPM %20.6122.22 - PBDT10.9710.04 9 PBT6.305.53 14 NP4.634.28 8 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Amanta Healthcare announces board meeting dateAmanta Healthcare will hold a meeting of the Board of Directors of the Company on 10 February 2026.Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Earnings
Amanta Healthcare standalone net profit declines 46.46% in the September 2025 quarterNet profit of Amanta Healthcare declined 46.46% to Rs 1.21 crore in the quarter ended September 2025 as against Rs 2.26 crore during the previous quarter ended September 2024. Sales rose 6.23% to Rs 70.89 crore in the quarter ended September 2025 as against Rs 66.73 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales70.8966.73 6 OPM %20.6720.80 - PBDT9.577.77 23 PBT4.913.17 55 NP1.212.26 -46 Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Corporate
Amanta Healthcare schedules board meetingAmanta Healthcare will hold a meeting of the Board of Directors of the Company on 11 November 2025.Powered by Capital Market - Live
10 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 11.05%, vs industry avg of 11.79%
Over the last 5 years, market share stayed at 0.06%